NantHealth EBIT

The latest EBIT for NHIQ is $-44M as of September 2023. That compares with $-49M in the prior-year period — up 8.9% year over year. That is below the Technology sector average of $14T. Investors often review this figure alongside NantHealth's historical trend and sector peers before judging valuation or financial health.

Over the past year, NHIQ's EBIT moved from $-49M to $-44M — a 8.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NantHealth's operating scale or balance-sheet position.

Against Technology companies, NHIQ currently prints $-44M for EBIT, while the sector average sits near $14T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at NantHealth's growth, margins, and balance sheet.

A EBIT figure of $-44M for NHIQ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Technology average is about $14T. Explore the charts below for those layers of context.

After noting NHIQ's EBIT ($-44M), review year-over-year change from $-49M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.